Policy Number

CD-PT-020

Management of COVID-19 Therapeutics - Care Directive - CD-PT-020

Description

This care directive (CD) provides the Regulated Health Care Provider (RHCP) with the authority and conditions under which they may:

   Initiate peripheral intravenous (IV) access for IV infusion of COVID-19 therapeutics

   Accessing a Central Venous Access Device (CVAD) for the administration of COVID-19 therapeutics

   Administer COVID-19 therapeutics, and

   Manage infusion-related reaction or anaphylaxis reaction, if required.

EFFECTIVE JULY 18th, 2022